Not finding it? Sign in to also search OpenAlex live.
-
Data from Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano, Hans A. J. Gelderblom, Nicolas Mach, Toshihiko Doi, David Wai-Meng Tai, Patrick M. Forde, +13 more
0citations -
Data from Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano, Hans A. J. Gelderblom, Nicolas Mach, Toshihiko Doi, David Wai-Meng Tai, Patrick M. Forde, +13 more
0citations
7 results